Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Open-Label, Randomised, Two-Arm, Parallel-Group, Superiority Study to Assess Bioavailability and Practicability of Envarsus® Compared With Advagraf® in de Novo Liver Transplant Recipients (EnGraft)

NCT04720326 is registered in ClinicalTrials.gov with Edward Geissler as lead sponsor.

NCT NCT04720326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04720326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Open-Label, Randomised, Two-Arm, Parallel-Group, Superiority Study to Assess Bioavailability and Practicability of Envarsus® Compared With Advagraf® in de Novo Liver Transplant Recipients (EnGraft)
Lead sponsor
Edward Geissler
Phase
Phase 4
Overall status
Active, not recruiting
Start date
December 23, 2020
Completion date
October 31, 2026
Enrollment
268 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

prophylaxis against liver transplant rejection